Meeting
2023 ASCO Annual Meeting
Characterizing KRAS allele variants within biliary tract cancers.
Authors
Gordon Taylor Moffat
Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, ON, Canada
Gordon Taylor Moffat , Zishuo Ian Hu , Anaemy Danner De Armas , Jeffrey S. Ross , Milind M. Javle , Jennifer J. Knox
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Track
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Sub Track
Hepatobiliary Cancer - Advanced/Metastatic Disease
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 4088)
DOI
10.1200/JCO.2023.41.16_suppl.4088
Abstract #
4088
Poster Bd #
409
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Genomic and immune landscape of biliary tract cancers with ARID1A, PBRM1, and BAP1 alterations.
First Author: Gentry Teng King
Poster
2023 ASCO Gastrointestinal Cancers Symposium
The efficacy of immune checkpoint inhibitors in biliary tract cancer with KRAS mutation.
First Author: Sun Young Jeong
Poster
2021 ASCO Annual Meeting
Genomic alterations for novel targeted therapies in pancreatobiliary cancers from real-world data.
First Author: Kumiko Umemoto
Poster
2020 ASCO Virtual Scientific Program
Characterization of KRAS mutations (mt) in non-small cell lung cancer (NSCLC).
First Author: Stephen V. Liu